Drug injection fades as smoking grows more common, marking sea change in U.S. fentanyl epidemic
-
By
-
Lev Facher
-
February 12, 2026
-
Clinical Scorecard: Shift from Drug Injection to Smoking Reflects Significant Change in the U.S. Fentanyl Crisis
At a Glance
| Category | Detail |
|---|
| Condition | Opioid Use Disorder |
| Key Mechanisms | Shift from injecting to smoking opioids to reduce health risks. |
| Target Population | Individuals using opioids, particularly fentanyl. |
| Care Setting | Community harm reduction organizations. |
Key Highlights
- Smoking opioids reduces risks of infections and overdose compared to injecting.
- The shift from injecting to smoking has become pronounced since the Covid-19 pandemic.
- Harm reduction supplies now include glass pipes and foil to facilitate smoking.
- Research indicates smokers may be 30% less likely to overdose than injectors.
- Public health strategies have been slow to adapt to changing drug use behaviors.
Guideline-Based Recommendations
Diagnosis
- Recognize the shift in drug use patterns from injection to smoking.
Management
- Provide harm reduction supplies including smoking kits to reduce health risks.
Monitoring & Follow-up
- Track overdose rates and health outcomes associated with smoking versus injecting.
Risks
- Monitor for potential backlash against harm reduction strategies, including smoking kits.
Patient & Prescribing Data
Individuals at risk of opioid overdose and infectious diseases.
Encouraging smoking as an alternative to injecting can improve health outcomes.
Clinical Best Practices
- Distribute harm reduction supplies that include smoking alternatives.
- Educate users on the benefits of smoking over injecting to reduce health risks.
- Engage with community organizations to adapt to changing drug use behaviors.
References
